Heidi Rossmann, Andreas Ziegler, Patrick Diemert, Willem H. Ouwehand, Claire Perret, Philipp S. Wild, Augusto Rendon, Raphaële Castagné, François Cambien, Christian Hengstenberg, Medea S. Eleftheriadis, C. Sinning, Maxime Rotival, Arne Schillert, Panos Deloukas, Renate B. Schnabel, Edith Lubos, Tiphaine Godefroy, Marine Germain, Laurence Tiret, Silke Szymczak, Seraya Maouche, Heribert Schunkert, Carole Proust, David-Alexandre Trégouët, Stefan Blankenberg, Tanja Zeller, Jeanette Erdmann, Thomas Münzel, Alison H. Goodall, Karl J. Lackner, Jessy Brocheton, Arne Deiseroth, Nilesh J. Samani, Gilles Montalescot, Autard, Delphine, Génomique cardiovasculaire, Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM), Medizinische Klinik und Poliklinik, Universitätsmedizin der Johannes-Gutenberg Universität Mainz, Medizinische Klinik II, Universität zu Lübeck = University of Lübeck [Lübeck], Institut für Medizinische Biometrie und Statistik, Institut für Klinische Chemie und Laboratoriumsmedizin, Department of Haematology, University of Cambridge [UK] (CAM), MRC Biostatistics Unit, Medical Research Council, Human Genetics, The Wellcome Trust Sanger Institute [Cambridge], Klinik und Poliklinik für Innere Medizin II, Universität Regensburg (UR), Department of Cardiovascular Sciences [Leicester], University of Leicester, Leicester NIHR Biomedical Research Unit in Cardiovascular Disease, The Gutenberg Health Study is funded through the government of Rheinland-Pfalz ('Stiftung Rheinland Pfalz für Innovation', contract number AZ 961-386261/733), the research programs 'Wissen schafft Zukunft' and 'Schwerpunkt Vaskuläre Prävention' of the Johannes Gutenberg-University of Mainz, and its contract with Boehringer Ingelheim and PHILIPS Medical Systems, including an unrestricted grant for the Gutenberg Health Study. Specifically, the research reported in this article was supported by the National Genome Network 'NGFNplus' by the Federal Ministry of Education and Research, Germany (contract number project A3 01GS0833), and by joint funding from the Federal Ministry of Education and Research, Germany (contract BMBF 01KU0908A), and from the Agence Nationale de la Recherche, France (contract ANR 09 GENO 106 01), for the project CARDomics. The Cardiogenics Consortium (http://www.cardiogenics.eu/web/) is funded by the 6th Framework Program of the European Union (LSHM-CT-2006-037593). NJ Samani holds a Chair supported by the British Heart Foundation., Universität zu Lübeck [Lübeck], and Johannes Gutenberg - Universität Mainz = Johannes Gutenberg University (JGU)
One major expectation from the transcriptome in humans is to characterize the biological basis of associations identified by genome-wide association studies. So far, few cis expression quantitative trait loci (eQTLs) have been reliably related to disease susceptibility. Trans-regulating mechanisms may play a more prominent role in disease susceptibility. We analyzed 12,808 genes detected in at least 5% of circulating monocyte samples from a population-based sample of 1,490 European unrelated subjects. We applied a method of extraction of expression patterns—independent component analysis—to identify sets of co-regulated genes. These patterns were then related to 675,350 SNPs to identify major trans-acting regulators. We detected three genomic regions significantly associated with co-regulated gene modules. Association of these loci with multiple expression traits was replicated in Cardiogenics, an independent study in which expression profiles of monocytes were available in 758 subjects. The locus 12q13 (lead SNP rs11171739), previously identified as a type 1 diabetes locus, was associated with a pattern including two cis eQTLs, RPS26 and SUOX, and 5 trans eQTLs, one of which (MADCAM1) is a potential candidate for mediating T1D susceptibility. The locus 12q24 (lead SNP rs653178), which has demonstrated extensive disease pleiotropy, including type 1 diabetes, hypertension, and celiac disease, was associated to a pattern strongly correlating to blood pressure level. The strongest trans eQTL in this pattern was CRIP1, a known marker of cellular proliferation in cancer. The locus 12q15 (lead SNP rs11177644) was associated with a pattern driven by two cis eQTLs, LYZ and YEATS4, and including 34 trans eQTLs, several of them tumor-related genes. This study shows that a method exploiting the structure of co-expressions among genes can help identify genomic regions involved in trans regulation of sets of genes and can provide clues for understanding the mechanisms linking genome-wide association loci to disease., Author Summary One major expectation from the transcriptome in humans is to help characterize the biological basis of associations identified by genome-wide association studies. Here, we take advantage of recent technical and methodological advances to examine the influence of natural genetic variability on >12,000 genes expressed in the monocyte, a blood cell playing a key role in immunity-related disorders and atherosclerosis. By examining 1,490 European population-based subjects, we identify three regions of the genome reproducibly associated with specific patterns of gene expression. Two of these regions overlap genetic variants previously known to be involved in the susceptibility to type 1 diabetes, celiac disease, and hypertension. Genes whose expression is modulated by these genetic variants may act as mediators in the causal relationship linking the variability of the genome to complex disease. These findings illustrate how integration of genetic and transcriptomic data at an epidemiological scale can help decipher the genetic basis of complex diseases.